Alteração de dados cadastrais
#1.1
07/07/2026
RPI 2896
Back to search
Application data
Number
112026016102Type
Invention Patent
Filing
01/09/2025
Publication
-
PCT
EP2025050383 Progress at the INPI
Examination not yet requested- Filing01/09/25
- Publication
- Examination
- Allowance
- Grant
- In force
Examination has not been requested yet. Without that request by 01/09/2028, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:01/09/2028(502 days left)
Latest action published by the INPI: 07/07/2026. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
VIVIDION THERAPEUTICS, INC.
US
Inventors
No inventors listed.
Technical data
IPC Classification
Priority claims
CN
PCT/CN2024/071830 · 01/11/2024
CN
PCT/CN2024/091669 · 05/08/2024
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Related
From the same holder
112026016287112026016392112026007431DERIVADOS DE 2-AZAESPIRO[3.3]HEPTANO COMO INIBIDORES DE STAT3 PARA O TRATAMENTO DO CÂNCERDERIVADOS DE 1-(([1,1?-BIFENIL]-2-IL)SULFONIL)-4-FLUORO-N-(3-(METILSULFONIL)ALIL)PIPERIDINA-4-CARBOXAMIDA COMO MODULADORES DE RAS-PI3K PARA O TRATAMENTO DE, POR EXEMPLO, CÂNCERDERIVADOS DE N-ACRILOILMORFOLINA COMO MODULADORES DE KEAP1 E USOS DOS MESMOSCOMPOSTOS, MÉTODOS PARA TRATAR UMA DOENÇA PROLIFERATIVA EM UM PACIENTE E PARA INIBIR HELICASE WRN E PROTEÍNA HELICASE WRN MODIFICADA
Same category
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.